Skip to main content

Table 3 Change in follow-up variables at 3, 6, and 12 months after the baseline visit among all participants, by smoking status (continuous abstinence vs. relapse)

From: Leptin and smoking cessation: secondary analyses of a randomized controlled trial assessing physical activity as an aid for smoking cessation

  3 months   6 months   12 months  
  Smoking Abstinence p Smoking Abstinence p Smoking Abstinence p
Body weight [Kg] 2.25 (2.35) 1.99 (2.83) 0.584 3.05 (4) 2.45 (6.15) 0.599 2.45 (3.64) 3.2 (7.42) 0.520
BMI [kg/m2] 0.78 (0.89) 0.68 (0.95) 0.539 1.08 (1.44) 0.86 (1.87) 0.535 0.84 (1.2) 1.1 (2.29) 0.468
Body fat [%] 1.49 (3.19) 1.23 (4) 0.784 2.18 (3.1) 2.09 (6.01) 0.955 2.5 (2.84) 2.57 (5.47) 0.948
HOMA-IR 0.1 (1.56) 0.03 (1.03) 0.763 0.27 (1.2) 0.27 (0.93) 0.977 0.99 (2.32) 0.83 (1.54) 0.681
Fasting leptin [ug/l] 1.8 (4.3) 2.03 (3.67) 0.734 1.88 (6.82) 2.63 (4.59) 0.505 1.83 (4.14) 2.56 (5.44) 0.455
Ratio leptin/body fat 0 (0.15) 0.03 (0.17) 0.513 -0.02 (0.18) 0.02 (0.22) 0.529 0 (0.11) 0.03 (0.24) 0.564
  1. Values are expressed in means (standard deviation).